Key result
Oral iron succinate increased median ferritin levels from /L at baseline to /L at 3 months in non-anaemic patients with heart failure and iron deficiency.
Why the study?
Oral iron absorption is generally poor in heart failure, leading guidelines to not recommend oral iron, prompting investigation into whether oral iron succinate increases iron deposits.
Does oral iron succinate increase iron deposits in non-anemic patients with heart failure and iron deficiency?
Does oral iron succinate increase iron deposits in non-anemic patients with heart failure and iron deficiency?
Oral iron succinate significantly increased ferritin and TSAT in non-anemic patients with heart failure and iron deficiency, suggesting oral iron may be effective despite current recommendations.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for oral iron succinate in non-anemic HF with ID; leaves open efficacy and outcomes in randomized trials.
Introduction: Iron deficiency (ID) is often present (32% - 65%) in patients with heart failure (HF). Oral iron absorption in patients with HF is generally poor. This is the reason why oral treatment is not recommended. Aim: To test whether oral iron succinate significantly increases iron deposits in non-anaaemic patients with HF. Methods: ID was defined as ferritin 2+ plus 100 mg succinate) in the morning and one tablet at bedtime for at least 3 months. Hemoglobin, CRP, ferritin, iron, TSAT, and hepcidin were analyzed before starting treatment, at 6 weeks, and at 3 months end of study (EOS). Results: Five women and 15 men were included in the study. The level of ferritin increased significantly from baseline to 6 weeks (47 to 78 μg/L, p = 0.009) and baseline to EOS (47 to 85 μg/L, p = 0.001). TSAT increased significantly from baseline to 6 weeks (20% to 27%, p = 0.046) and baseline to EOS (20% to 25%, p = 0.043). Hepcidin increased significantly from baseline to 6 weeks (2.5 nmol/L to 4.8 nmol/L, p = 0.006) and baseline to EOS (2.5 to 4.2 nmol/L, p = 0.02). Conclusion: Oral iron succinate significantly increased iron uptake, almost doubling the ferritin levels and increasing the TSAT, in patients with HF. Our findings challenge the opinion that oral iron treatment cannot significantly increase iron deposits in non-anemic patients with ID and HF.
No takes yet. Share an insight, caveat, or question.
Boman et al. (2021) studied Heart failure with iron deficiency (n=20). Iron succinate vs. Baseline was evaluated on Ferritin level at 3 months (p=0.001). Oral iron succinate increased median ferritin levels from /L at baseline to /L at 3 months in non-anaemic patients with heart failure and iron deficiency.
Synapse has enriched 10 related papers. Consider them for comparative context: